Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.
about
Markers of bacterial translocation in end-stage liver diseaseProcalcitonin in liver transplantation: are high levels due to donors or recipients?Significance of serum procalcitonin as biomarker for detection of bacterial peritonitis: a systematic review and meta-analysis.Study of adiponectin in chronic liver disease and cholestasis.Association between C-reactive protein, incident liver cancer, and chronic liver disease mortality in the Linxian Nutrition Intervention Trials: a nested case-control study.Procalcitonin Identifies Cell Injury, Not Bacterial Infection, in Acute Liver FailureBlood Procalcitonin Predicts Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and AscitesAST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis.Prognostic and diagnostic value of procalcitonin in the post-transplant setting after liver transplantation.The role of serum procalcitonin levels in predicting ascitic fluid infection in hospitalized cirrhotic and non-cirrhotic patientsProcalcitonin and C-reactive protein in the diagnosis and prediction of spontaneous bacterial peritonitis associated with chronic severe hepatitis BPresepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis.Impact of hepatic function on serum procalcitonin for the diagnosis of bacterial infections in patients with chronic liver disease: A retrospective analysis of 324 cases.C-reactive protein level as a predictor of mortality in liver disease patients with bacteremia.Postoperative atrial fibrillation: role of inflammatory biomarkers and use of colchicine for its prevention.Biomarkers in Hepatic Disease: A Review Focused on Critically Ill Patients.New prognostic markers in liver cirrhosis.Biomarkers for the early diagnosis of bacterial infection and the surveillance of hepatocellular carcinoma in cirrhosis.Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT1-ROS-ERK1/2 signaling pathway in hepatocytes.A Novel Combination of C-Reactive Protein and Vascular Endothelial Growth Factor in Differential Diagnosis of Ascites.Clinical characteristics and prognostic factors of liver cirrhosis patients with systemic inflammatory response syndrome.Liver transplantation in patients with liver cirrhosis and active pneumonia: an observational study.Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study.Bacterial translocation markers in liver cirrhosis.Prognostic significance of serum procalcitonin in patients with unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization: A retrospective analysis of 509 cases.Predictive value of C-reactive protein in critically ill patients after abdominal surgery.Diagnostic Accuracy of Serum Procalcitonin for Spontaneous Bacterial Peritonitis Due to End-stage Liver Disease: A Meta-analysis.Prognostic value of C-reactive protein levels in patients with cirrhosis.C-reactive protein and bacterial infection in cirrhosis.Comment on Mackenzie and Woodhouse: C-reactive protein concentrations during bacteraemia: a comparison between patients with and without liver dysfunction.Interpretation of C-reactive protein concentrations in critically ill patients.Bacterial infections in patients with liver cirrhosis: clinical characteristics and the role of C-reactive protein.Possible Synergistic Effects of Glutathione and C-Reactive Protein in the Progression of Liver Cirrhosis.Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections
P2860
Q26783888-749BBF44-6212-49E7-8379-98D9FA493758Q33349213-96D9F508-899F-4E6C-B81C-C3C025C7A673Q34136205-1541C0F3-5DF9-4FAE-A209-BC42E346BC40Q34365487-BA25F98B-2031-485B-B43B-6410CA866542Q35071202-C4883929-F506-4928-8BD4-A95078117D78Q35783372-0751BD77-8DD7-440C-8661-19D70EDC5B9CQ36029583-BF589892-2C53-4D4B-8A31-0F50B26ACD4CQ36664042-50758316-0BEF-4701-8A50-927DE7286F78Q36845330-35451605-4B89-4AF9-B536-B9E86D824FE8Q37119332-BFD54DEF-C64C-47D3-8BA9-C15F1DDF48BEQ37284988-FEE0A379-577E-49B7-8375-6F5A46CAB7E8Q37411315-7E810032-AE8D-40B5-B1E5-9D11637A58EAQ37605619-F32CEFBD-333B-420A-83DD-8E630A6346FFQ37929801-B6B7F9A4-5458-4FAF-8F2C-9386F06F8CE8Q38256854-A34D7F48-C924-440E-9928-F1DF63402A90Q38260980-856DCF06-A6B0-4932-8C2A-2A441887433BQ38505401-5802C4CE-8BE5-4D14-BA69-1E60CBB24531Q38637305-69BA044D-D5AC-4588-8B8F-29CB1462931EQ38753755-28AEE807-7F96-4BB9-8D6E-61E001C6F904Q38855207-3B201C89-0FB6-4EC2-A833-F921CD0094EEQ38935400-24631C77-C7EF-4F89-AF8E-D91B25B3C74AQ39204563-D2178489-AA04-4E9B-AEA7-0178C00E29E3Q39373943-F300BF27-0021-4721-83AF-56C6D10503BFQ40078218-B5C6B833-29BD-4B2A-847D-5990ABAFB851Q40125882-184A130F-F6B9-4539-B57C-66700F34FF55Q40321934-2A5DF52B-3142-4387-8249-CD364BA05432Q40875663-309279A7-C718-4C22-A31C-31FBFDC78AECQ41441674-F52FF59D-4BF1-4129-BE72-D879FB7AE2B3Q42360902-98310D18-0FA8-474E-B656-C8952530C1AEQ42583138-F06948B4-CEAB-4A2D-8F3A-547E74B24420Q42909180-EC1990D5-3C5A-433E-8F19-AB6F41170161Q47431015-275ED9E9-B86B-4E07-BD39-F5ECA5E0B5A9Q55515131-C0BB3A76-FA34-4F14-89A2-4462BA5A25AEQ57089314-F29E367F-7A94-4C09-98D7-0EE0C12BAE47
P2860
Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Serum levels of C-reactive pro ...... s with cirrhosis of the liver.
@en
Serum levels of C-reactive pro ...... s with cirrhosis of the liver.
@nl
type
label
Serum levels of C-reactive pro ...... s with cirrhosis of the liver.
@en
Serum levels of C-reactive pro ...... s with cirrhosis of the liver.
@nl
prefLabel
Serum levels of C-reactive pro ...... s with cirrhosis of the liver.
@en
Serum levels of C-reactive pro ...... s with cirrhosis of the liver.
@nl
P2093
P1476
Serum levels of C-reactive pro ...... s with cirrhosis of the liver.
@en
P2093
Ahmed N Zakariah
Daliana Peres Bota
Marc Van Nuffelen
P304
P356
10.1016/J.LAB.2005.08.005
P577
2005-12-01T00:00:00Z